Sustained Glycemic Control After Surgical Resection of Olfactory Groove Meningiomas - Scorecard - MDSpire

Sustained Glycemic Control After Surgical Resection of Olfactory Groove Meningiomas

  • By

  • Austin J. Leikvoll

  • Matthew Awad

  • A. Yohan Alexander

  • Sharath Anand

  • Zachary Gersey

  • Kolin Rubel

  • Neal Godse

  • Emiro Caicedo-Granados

  • Georgios Zenonos

  • Takako Araki

  • Michael Lee

  • Collin McClelland

  • Paul A. Gardner

  • Andrew S. Venteicher

  • June 3, 2026

  • 0 min

Share

Clinical Scorecard: Long-Term Glycemic Improvement Following Surgical Removal of Olfactory Groove Meningiomas

At a Glance

CategoryDetail
Condition
Key MechanismsPotential multifactorial mechanisms including mass effect, neuroinflammation, and edema in the frontal lobes affecting executive function. [Needs source attribution]
Target Population
Care Setting

Key Highlights

  • Postoperative mean HbA1c decreased from 9.2% to 6.4% within 9 months.
  • Durable glycemic control improvement observed at 36 months post-surgery.
  • Mean BMI decreased by 5.3 postoperatively.
  • Metabolic improvement noted in all but one patient.

Guideline-Based Recommendations

Diagnosis

    Management

    • Surgical resection may be considered for patients with OGMs and comorbid diabetes. [Needs source attribution]

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients with olfactory groove meningiomas and diabetes.

        Nine patients were on antidiabetic therapy preoperatively; most maintained similar or less intensive regimens post-surgery.

        Clinical Best Practices

        • Evaluate frontal lobe function in patients with OGMs.
        • Monitor metabolic outcomes following surgical intervention.

        Related Resources & Content

        Original Source(s)

        Sustained Glycemic Control After Surgical Resection of Olfactory Groove Meningiomas

        • by Austin J. Leikvoll, Matthew Awad, A. Yohan Alexander, Sharath Anand, Zachary Gersey, Kolin Rubel, Neal Godse, Emiro Caicedo-Granados, Georgios Zenonos, Takako Araki, Michael Lee, Collin McClelland, Paul A. Gardner, Andrew S. Venteicher

        • June 3, 2026

        Related Content

        Development and internal validation of a risk prediction model for ipsilateral upper-limb lymphedema following breast cancer surgery

        CAA Use Tied to Higher Arthroplasty Risk

        In a UK cohort, patients with osteoarthritis who initiated centrally acting analgesics had a higher hazard of knee or hip replacement than those who initiated SSRIs, though residual confounding by pain severity remains a key limitation.

        Celiac Tied to Higher Transplant Rate

        Liver transplantation showed the strongest association, although absolute event rates remained low in a nationwide Swedish cohort study.